This conclusion brings together the core lessons from the “Making it Count” series, which has provided a forward-looking toolkit for translating sustainability ambition into enterprise value.
Postdischarge adverse drug event risk is amplified by frequent medication changes, formulary substitutions, and insurance coverage gaps, with wide variability in published incidence estimates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results